MDM2 inhibitor APG-115 synergizes with ABT-199 to induce cell apoptosis in chronic lymphocytic leukemia
Although clinical outcomes in chronic lymphocytic leukemia (CLL) have greatly improved with several approved small molecular inhibitors, acquired resistance does occur, leading to disease progression and eventual death. Thus, the effort to explore novel inhibitors and combination therapeutic regimen...
Saved in:
Main Authors: | Ying Cui (Author), Xiaoya Shao (Author), Haiping Yang (Author), Jingyi Xin (Author), Yuanyuan Liu (Author), Mingxiao Zhang (Author), Chuanyue Sun (Author), Ge Chen (Author), Guomin Shen (Author), Xueqiong Meng (Author), Yixiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma
by: Zide Chen, et al.
Published: (2018) -
Sensitization effect of kaempferol from persimmon leaves on HepG2 hepatoma cells with ABT-199 resistance and its molecular mechanisms
by: Li Chen, et al.
Published: (2022) -
Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions
by: Johanna Weiss, et al.
Published: (2016) -
Establishment and genetically characterization of patient-derived xenograft models of cervical cancer
by: Shuangwei Zou, et al.
Published: (2022) -
The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis
by: Ruochan Chen, et al.
Published: (2023)